Table 2.
Age [mean(SD); median (range)] | Gender | |
---|---|---|
Lymphoma = 48 (21) | 48 (15.1); 51 (14–69) |
M = 22 (46) F = 18 (37) NA = 8 (17) |
Renal cell carcinoma = 42 (18) | 44.2 (16.8); 47.5 (9–69) |
M = 27 (64) F = 12 (29) NA = 3 (7) |
Melanoma = 40 (17) | 47.8 (13.4); 47.5 (19–70) |
M = 10 (25) F = 13 (33) NA = 17 (42) |
NSCLC = 13 (6) | 38.5 (10); 39 (18–53) |
M = 10 (77) F = 2 (15) NA = 1 (8) |
Neuroendocrine = 11 (5) | 44.2 (11.3); 41 (25–64) |
M = 5 (45) F = 4 (36) NA = 2 (18) |
Choriocarcinoma = 10 (4) | 29.9 (9.8); 27 (20–47) |
M = 2 (20) F = 6 (60) NA = 2 (20) |
Glioblastoma = 6 (3) | 31.5 (11.8); 27.5 (23–48) |
M = 2 (33) F = 2 (33) NA = 2 (33) |
Breast cancer = 5 (2) | 38 (19.7); 37.5 (15–62) |
M = 3 (60) F = 2 (40) |
Leukemia = 9 (4) | 56.8 (17.4); 58 (21–77) |
M = 2 (22) F = 4 (44) NA = 3 (33) |
Other = 50 (21) | 47.2 (15.3); 50 (1.42–71) |
M = 26 (52) F = 17 (34) NA = 7 (14) |
Total = 234 (100) | 45.4 (15.5); 47 (1.42–77) |
M = 109 (47) F = 80 (34) NA = 45 (19) |
Apart from age, numbers represent absolute values with percentages in parentheses
F female, M male, NA not available, NSCLC non-small cell lung cancer, SD standard deviation